Also found in: Dictionary, Thesaurus, Medical, Idioms.


Biological products used to induce immunity to various infectious diseases or noxious substances of biological origin. The term is usually limited to immune serums, antitoxins, vaccines, and toxoids that have the effect of providing protective substances of the same general nature that a person develops naturally from having survived an infectious disease or having experienced repeated contact with a biological poison. As a matter of governmental regulatory convenience, certain therapeutic substances which have little to do with conferring immunity have been classified as biological products primarily because they are derived from human or animal sources and are tested for safety by methods similar to those used for many biological products. See Immunity

One major class of biologicals includes the animal and human immune serums. All animals, including humans, develop protective substances in their blood plasma during recovery from many (but not all) infectious diseases or following the injection of toxins or killed bacteria and viruses. These protective substances, called antibodies, usually are found in the immunoglobulin fraction of the plasma and are specific since they react with and neutralize only substances identical or closely similar to those that caused them to be formed. See Antibody, Immunoglobulin, Serum

Antibody-containing serum from another animal is useful in the treatment, modification, or prevention of certain diseases of humans when it is given by intramuscular or intravenous injection. The use of these preformed “borrowed” antibodies is called passive immunization, to distinguish it from active immunization, in which each person develops his or her own antibodies. Passive immunization has the advantage of providing immediate protection, but it is temporary because serum proteins from other animals and even from other humans are rapidly destroyed in the recipient.

Serums which contain antibodies active chiefly in destroying the infecting virus or bacterium are usually called antiserums or immune serums; those containing antibodies capable of neutralizing the secreted toxins of bacteria are called antitoxins. Immune serums have been prepared to neutralize the venoms of certain poisonous snakes and black widow spiders; they are called antivenins.

Because all products used for passive immunization are immune serums, or globulin fractions from such serums, they are named to indicate the diseases that they treat or prevent, the substances that they inhibit or neutralize, the animal from which they came, and whether they are whole serums or the globulin fractions thereof. Thus there is, for example, antipertussis immune rabbit serum, measles immune globulin (human), diphtheria antitoxic globulin (horse), tetanus immune globulin (human), and anti-Rh0 (D) gamma globulin (human).

The use of animal immune serums for prevention of therapy in humans has certain disadvantages. The serum proteins themselves may cause the production of specific antibodies in the recipient of the immune serum, and thus the person may become allergically sensitized to the serum protein of this animal species. See Anaphylaxis, Hypersensitivity

Products used to produce active immunity constitute the other large class of biological products. They contain the actual toxins, viruses, or bacteria that cause disease, but they are modified in a manner to make them safe to administer. Because the body does not distinguish between the natural toxin or infectious agent and the same material when properly modified, immunity is produced in response to injections of these materials in a manner very similar to that which occurs during the natural disease. Vaccines are suspensions of the killed or attenuated (weakened) bacteria or viruses or fractions thereof. Toxoids are solutions of the chemically altered specific bacterial toxins which cause the major damage produced by bacterial infections. Biological products producing active immunity are usually named to indicate the disease they immunize against and the kind of substance they contain: thus typhoid vaccine, diphtheria toxoid, tetanus toxoid, measles vaccine, mumps vaccine, and poliomyelitis vaccine. See Vaccination

Another group of biological products consists of reagents used in the diagnosis of infectious diseases. These include immune serums for the serological typing and identification of pathogenic bacteria and viruses, and various antigens for the detection of antibodies in patients' serums as a means of assisting in diagnosis.

References in periodicals archive ?
Pre-clinical studies undertaken by Virosome Biologicals with their technology have shown an immune response to influenza (flu) vaccines up to 150 times greater than traditional non-adjuvanted virosome delivery technology.
The arrangement entered into offers NIM a low-risk window into Virosome Biologicals for a limited financial commitment.
Combination Therapies: Benefits and Challenges in Drug, Device, and Biologicals Development looks at the history of combination therapies (drug-drug, drug-device, and drug-biological), explains FDA guidelines on combination products, discusses how patents play a role in decision-making, and examines different approaches the pharmaceutical industry has taken with regard to combination products and patent extensions.
This effort starts with the elimination of animal tissues in animal feed and continues with the use of technologies that effectively remove prions from biological products and the blood supply.
The national and international "GXP" regulations required in R&D and manufacturing facilities handling biologicals and biopharmaceuticals.
In 2000, GSK Biologicals and MVI entered into a partnership to develop the vaccine for children.
Proliant Biologicals is a primary manufacturer of Bovine Serum Albumin, IgG, transferrin and lipoprotein for use as components of diagnostic/medical device manufacturing, biopharmaceutical production, veterinary manufacturing and life-science research.
Proliant Biologicals is part of The Lauridsen Group International, a private, Ankeny, Iowa-based holding company that includes Proliant Dairy and Meat Ingredients companies, Proliant Health, American Protein Corporation and Boyer Valley Corporation.
Aventis licensed LifeCycle Biologicals Manager for use in their Industrial Operations business unit, which is involved in the development and scale-up of microbial strains and vectors for producing therapeutic compounds through fermentation and cell culture methods.
LifeCycle Biologicals Manager was developed with leading pharmaceutical and biotechnology companies who are facing the growing challenge of effectively leveraging their biological assets," said Jamie Duke, vice president of products, operations and strategy for SciQuest.
Our relationship with Corixa in the field of cancer vaccine antigen discovery has been a great success," said Moncef Slaoui, vice president of new products at GlaxoSmithKline Biologicals.
GlaxoSmithKline Biologicals (GSK Biologicals), the vaccine research, development and production center of GlaxoSmithKline (NYSE: GSK) and Biosynexus announce today that they have entered into an exclusive collaborative agreement to develop and commercialize staphylococcal antibodies and vaccines to prevent and treat infections caused by staphylococcal bacteria.

Full browser ?